US$ 28.29
metformin and glp 1 together GLP-1 RA initiation versus risk of cardiomyopathy in patients with cancer and diabetes treated with chemotherapy, radiation, or immunotherapy: a target trial emulation Comparative effectiveness of combining antidiabetic
Description
Twice-daily formulations such as immediate-release exenatide (Byetta) have more specific timing requirements

Corrado M, Mariotti FR, Trapani L, Taraborrelli L, Nazio F, Cianfanelli V, et al

Ma X, Liu Z, Ilyas I, Little PJ, Kamato D, Sahebka A, Chen Z, Luo S, Zheng X, Weng J, et al

They redirected clinical questions to the in-app care team

they produce substantial weight loss, reduce cardiovascular events, protect kidneys, and improve fatty liver disease

Perspectives in GLP-1 research: new targets, new receptors
